Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Glucose + caffeine** is a combination of two active ingredients, commonly present in beverages such as energy drinks and some pharmaceutical formulations. Glucose serves as a rapid source of metabolic energy for brain and muscle activity, while caffeine acts as a central nervous system stimulant, antagonizing adenosine receptors to promote wakefulness, enhance alertness, and improve cognitive performance. Studies in healthy adults show that the co-administration of glucose and caffeine synergistically enhances cognitive processes, such as sustained attention, working memory, and multi-tasking ability, more effectively than either glucose or caffeine alone[1][2][4]. This combination increases the efficiency of brain activity, evidenced by improved performance in complex cognitive tasks and reduced neural activation in relevant brain regions, indicating greater neural efficiency[2]. These improvements are believed to result from complementary metabolic and neurostimulatory actions: glucose supports energy-demanding cognitive processes, while caffeine increases attentional resources, executive functioning, and processing speed[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucose + caffeine.